GeminIQ Website Logo

Viewing ZLAB free

Subscribe for full history, 90+ metrics, screener, watchlist...

Zai Lab Ltd

ZLAB

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
608651680717732757450616630651790789
Restricted Cash Current
1001001001001001001001001001000-
Short Term Investments
1010100003300001632
Accounts Receivable Net Current
7054106858877855070605942
Financing Receivable Excluding Accrued Interest Af…
-812201111419815624
Inventory Net
918675676253404042384544
Prepaid Expense And Other Assets Current
333537444144423620242330
Assets Current
9149451,0191,0331,0341,0421,050861870889940960
Restricted Cash Noncurrent
111111111112
Property Plant And Equipment Net
464747495050485151525455
Long Term Investments
------3341494
Operating Lease Right Of Use Asset
161819161719211313151516
Intangible Assets Net Excluding Goodwill
86767655575656524412132
Deferred Income Tax Assets Net
533---0-----
Other Assets Noncurrent
4332336-----
Deposits Assets Noncurrent
------111111
Assets
1,0751,0961,1721,1591,1641,1731,1869859879881,0361,044
Value Added Tax Receivable Noncurrent
------11--0-
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
1371261421001071031011211278811355
Operating Lease Liability Current
566567878877
Short Term Borrowings
23821420520317517313211370480-
Other Liabilities Current
494764524437594646488363
Liabilities Current
429393416360332320299286252192203125
Deferred Income Noncurrent
282927282930312525262928
Operating Lease Liability Noncurrent
11121311111214668810
Other Liabilities Noncurrent
000000000000
Liabilities
468434457399372363345318283226240163
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
3,3713,3583,3433,3283,3083,2843,2643,0323,0122,9932,9752,954
Retained Earnings Accumulated Deficit
-2,730-2,680-2,629-2,578-2,542-2,502-2,453-2,371-2,330-2,249-2,196-2,101
Accumulated Other Comprehensive Income Loss Net Of…
01530404649512843393848
Treasury Stock Common Value
-34-31-29-29-21-21-21-21-21-21-21-21
Stockholders Equity
607662716760792811841668704762796881
Liabilities And Stockholders Equity
1,0751,0961,1721,1591,1641,1731,1869859879881,0361,044
Allowance For Doubtful Accounts Receivable Current
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
5,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,000
Common Stock Shares Issued
1,1321,1191,1141,1131,1041,0891,083989986978977974
Shares Outstanding
1,1221,1101,1061,1061,0991,0841,078984981973972969
Treasury Stock Common Shares
1097755555555

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-10.50%-8.93%-2.76%---------
20253.43%19.22%27.56%-2.88%-7.22%-22.77%-11.84%-20.82%-20.82%-8.13%22.85%4.57%
20247.30%4.59%13.82%10.10%30.48%78.74%-3.42%-12.64%-6.11%2.07%-16.11%-10.03%
2023----1.36%-8.13%-11.19%-2.86%-3.46%-19.68%-28.06%-37.44%-13.74%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.13
2.40
2.45
2.87
3.12
3.26
3.51
3.01
3.46
4.63
4.63
7.68
Quick Ratio
1.84
2.10
2.18
2.56
2.81
2.95
3.24
2.74
3.21
4.30
4.29
7.09
Working Capital
485.45M
551.75M
603.12M
673.18M
702.56M
722.06M
751.10M
574.23M
618.21M
696.53M
736.54M
834.84M
Leverage & Debt
Debt to Equity
0.77
0.66
0.64
0.53
0.47
0.45
0.41
0.48
0.40
0.30
0.30
0.18
Interest Coverage TTM
-44.13
-42.85
-44.05
-47.95
-60.26
-80.56
-125.16
-250.52
-585.00
-3,250.97
-
-
Debt Ratio
0.44
0.40
0.39
0.34
0.32
0.31
0.29
0.32
0.29
0.23
0.23
0.16
Efficiency & Turnover
Asset Turnover TTM
0.40
0.39
0.39
0.41
0.40
0.39
0.36
0.35
0.31
0.27
0.24
0.23
Days Sales Outstanding TTM
65.06
53.42
76.36
56.31
67.82
59.95
66.27
46.97
66.12
65.06
67.85
47.91
Receivables Turnover TTM
5.61
6.83
4.78
6.48
5.38
6.09
5.51
7.77
5.52
5.61
5.38
7.62
Per Share Metrics
Diluted EPS TTM
-0.17
-0.16
-0.16
-0.19
-0.19
-0.23
-0.26
-0.28
-0.31
-0.35
-0.35
-0.31
Free Cash Flow Per Share TTM
-0.17
-0.10
-0.15
-0.12
-0.11
-0.18
-0.22
-0.18
-0.21
-0.23
-0.21
-0.31
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
144.09%
142.66%
141.67%
138.76%
137.55%
136.44%
137.00%
136.70%
137.02%
137.14%
135.92%
134.65%
Operating Profit Margin TTM
-59.55%
-54.34%
-50.18%
-51.96%
-58.03%
-64.30%
-70.95%
-95.07%
-109.67%
-126.21%
-137.44%
-128.70%
Net Profit Margin TTM
-42.44%
-39.91%
-38.40%
-47.15%
-49.94%
-60.46%
-64.66%
-76.13%
-92.44%
-116.45%
-125.46%
-113.96%
Growth Metrics
Net Revenue Growth (1Y)
4.22%
7.03%
14.98%
23.30%
31.86%
43.25%
49.08%
34.71%
27.86%
25.94%
24.03%
34.88%
Net Income Growth (1Y)
-11.44%
-29.34%
-31.73%
-23.64%
-28.76%
-25.63%
-23.17%
-10.01%
-24.09%
-17.34%
-24.51%
-49.28%
EPS Growth (1Y)
-13.42%
-31.03%
-38.32%
-31.98%
-36.33%
-33.04%
-24.96%
-11.19%
-24.95%
-18.33%
-25.16%
-49.78%
Valuation Metrics
P/E TTM
-112.76
-116.95
-110.07
-180.60
-179.68
-154.96
-100.79
-87.50
-56.69
-45.99
-78.93
-78.25
P/B TTM
34.96
31.47
27.00
49.15
48.23
48.18
30.82
35.49
24.02
20.45
33.18
26.73
P/S TTM
47.85
46.68
42.26
85.15
89.73
93.68
65.17
66.61
52.41
53.56
99.02
89.18
Market Cap
21.22B
20.83B
19.32B
37.35B
38.18B
39.06B
25.91B
23.70B
16.91B
15.59B
26.41B
23.55B
Enterprise Value
20.85B
20.39B
18.85B
36.84B
37.63B
38.48B
25.60B
23.19B
16.35B
14.99B
25.62B
22.76B
Calculated Values
Free Cash Flow TTM
-189.70M
-108.76M
-158.89M
-127.33M
-120.44M
-192.68M
-220.53M
-177.30M
-206.16M
-223.67M
-205.39M
-303.96M
Net Debt
-369.42M
-437.50M
-475.04M
-514.13M
-557.65M
-583.86M
-317.96M
-503.09M
-559.75M
-602.51M
-790.15M
-788.81M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-26Sale
Owner: Edmondson, Frazor Titus I…
Title: Chief Legal Officer
Shares: 4,103
Price/Share: $17.46
Value: $71,638.38
Shares Owned: 30,346
Relationship: Officer
Ownership: Direct
2026-06-26Sale
Owner: Du, Ying
Title: Chairperson & CEO
Shares: 24,543
Price/Share: $17.46
Value: $428,520.78
Shares Owned: 1,192,840
Relationship: Director,Officer
Ownership: Direct
2026-06-26Sale
Owner: Chen, Yajing
Title: Chief Financial Officer
Shares: 2,264
Price/Share: $17.46
Value: $39,529.44
Shares Owned: 35,691
Relationship: Officer
Ownership: Direct
2026-06-22Sale
Owner: Lis, William
Title: -
Shares: 7,040
Price/Share: $18.09
Value: $127,353.60
Shares Owned: 50,437
Relationship: Director
Ownership: Direct
2026-05-18Sale
Owner: Du, Ying
Title: Chairperson & CEO
Shares: 50,000
Price/Share: $19.00
Value: $950,000.00
Shares Owned: 1,122,626
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
2.48%
Inst. Shares: 27,434,999
Shares Outstanding: 1,107,390,590
2025-12-31
2.52%
Inst. Shares: 27,615,114
Shares Outstanding: 1,095,311,090
2025-09-30
3.05%
Inst. Shares: 33,612,733
Shares Outstanding: 1,102,072,680
2025-06-30
3.82%
Inst. Shares: 41,758,114
Shares Outstanding: 1,091,933,150
2025-03-31
4.75%
Inst. Shares: 51,388,066
Shares Outstanding: 1,080,825,300

Zai Lab Ltd (ZLAB) — SEC Financial Statements & Analysis

Zai Lab Ltd (ZLAB) is a pharmaceutical preparations company, incorporated in E9. Zai Lab Ltd trades on Nasdaq as: ZLAB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Zai Lab Ltd reported a 4.22% year-over-year revenue growth, a Gross Profit Margin of 144.09% (TTM), a Debt-to-Equity ratio of 0.77x, a Price-to-Sales (P/S) ratio of 47.85x (TTM), a Price-to-Book (P/B) ratio of 34.96x (TTM), at a market cap of $21.22B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
4.22%
Gross Profit Margin TTM
144.09%
Debt To Equity
0.77x
P/S TTM
47.85x
P/B TTM
34.96x
Market Cap
$21.22B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Zai Lab Ltd in?

Zai Lab Ltd (ZLAB) operates in the Pharmaceutical Preparations industry.

What is ZLAB's market cap?

Zai Lab Ltd (ZLAB) has a market capitalization of $21.22B as of 2026-06-30.

What exchange does ZLAB trade on?

Zai Lab Ltd (ZLAB) trades on the Nasdaq.

Where is Zai Lab Ltd incorporated?

Zai Lab Ltd is incorporated in Cayman Islands.

Wall Street's data.
Main Street's price.